why choose us

First received: September 14, 2022

Clinical Trial: A Study of TAVO412 in Patients With Cancer

Study Status: Completed

Recruit Status: RECRUITING

Condition: Cancer

Study Type: INTERVENTIONAL


Official Title: A 2-Part Open-Label Phase I Study of TAVO412 in Patients With Advanced or Metastatic Solid Tumors Who Progressed on Prior Approved Standard of Care Therapy

Brief Summary: TAVO412 Phase 1 is an open-label, non-randomized, 2-part Phase I study to examine the safety, tolerability, pharmacokinetics/pharmacodynamics, and preliminary efficacy of TAVO412.Part 1 will utilize a standard 3 + 3 design to determine the MTD/RP2D of TAVO412 in subjects with advanced or metastatic solid tumors who progressed on prior approved standard of care therapy.Part 2 will further evaluate the safety, tolerability, preliminary efficacy, pharmacokinetics (PK), and pharmacologic activity of TAVO412…

Read more